Welcome to our dedicated page for So-Young Intl news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young Intl stock.
So-Young International Inc. (Nasdaq: SY) is described as the leading aesthetic treatment platform in China, connecting consumers with online services and offline treatments. The news flow around SY focuses heavily on quarterly financial and operational updates, corporate actions related to its listing, and developments in its branded aesthetic center network and product activities.
Investors following SY news will see regular unaudited financial results releases furnished on Form 6-K, covering revenue composition across aesthetic treatment services, information and reservation services, sales of medical products and maintenance services, and other services. These announcements also provide detail on cost of revenues, operating expenses, non-GAAP metrics and cash positions, giving readers insight into how So-Young’s business mix is evolving over time.
Operational highlights in So-Young’s news include the number of fully operational branded aesthetic centers in major Chinese cities, verified treatment visits, verified aesthetic treatments performed and active users visiting the centers. The company also discloses information on the number of institutions served with supply chain solutions for injectables and shipment volumes for injectable products such as Elasty, illustrating activity in its upstream product and supply chain segment.
Corporate and capital market updates are another recurring theme in SY news. So-Young has issued press releases on plans and timing for ADS ratio changes, as well as notifications about regaining compliance with Nasdaq’s minimum bid price requirement. The company also announces the filing of its annual report on Form 20-F and provides schedules and dial-in details for earnings conference calls.
For readers and investors, the SY news page offers a centralized view of So-Young’s financial performance, operational metrics, listing-related developments and strategic updates. Monitoring these releases can help track how the company’s aesthetic treatment platform, branded centers and medical aesthetic product activities are progressing over time.
So-Young International Inc. (Nasdaq: SY) announced its decision to acquire a controlling interest in Wuhan Miracle Laser Systems for a total of RMB 791 million. This acquisition is part of So-Young's strategy to capitalize on the growth potential in China's medical aesthetics industry, particularly in non-surgical segments. The transaction is expected to close in Q3 2021, subject to customary conditions. So-Young aims to leverage this acquisition to enhance its operational capabilities and provide greater returns to shareholders.
So-Young International Inc. (Nasdaq: SY) reported its financial results for Q1 2021, showing a 97.0% revenue increase to RMB359.6 million (US$54.9 million) compared to RMB182.6 million in Q1 2020. However, the company posted a net loss of RMB46.3 million (US$7.1 million), up from a net loss of RMB35.9 million a year earlier. Key operational metrics revealed an average mobile MAU increase of 101.0% to 8.4 million and a 123.3% rise in users purchasing reservation services. The company forecasts revenues between RMB430 million and RMB450 million for Q2 2021.
So-Young International Inc. (NASDAQ: SY) will announce its Q1 2021 financial results on May 19, 2021, before U.S. markets open. A conference call will follow at 7:30 AM U.S. Eastern Time, requiring preregistration due to COVID-19 restrictions. Participants will receive dial-in information upon registration. An archived webcast will also be available post-conference. So-Young, a leader in the medical aesthetics industry in China, connects consumers and service providers, leveraging its trustworthy content and user insights to drive growth in the healthcare market.
So-Young International Inc. (Nasdaq: SY) responds to a short seller report from Blue Orca Capital, asserting that it contains inaccuracies about the company. In reaction to market disturbances, So-Young announced a share repurchase plan of up to US$70 million over 12 months to demonstrate confidence in its long-term prospects. The company emphasizes its leading position in China's medical aesthetics social community and invites third-party verification of its financial performance.
So-Young International Inc. (Nasdaq: SY) has filed its annual report on Form 20-F for the fiscal year ending December 31, 2020, with the Securities and Exchange Commission as of April 30, 2021. This report includes audited consolidated financial statements and can be accessed through the company's investor relations website. Shareholders can request a hard copy of the report free of charge via email. So-Young is noted as a significant social community in China's medical aesthetics industry, emphasizing its brand strength and market position.
So-Young International Inc. (Nasdaq: SY) reported its Q4 and full-year 2020 financial results, revealing Q4 revenues of RMB424.6 million (US$65.1 million), marking an 18.6% increase year-over-year. However, net income fell to RMB37.7 million (US$5.8 million) from RMB69.9 million in 2019. For the entire year, total revenues reached RMB1,295.0 million (US$198.5 million), up 12.4% from 2019, yet net income drastically decreased to RMB4.9 million (US$0.7 million). The company anticipates Q1 2021 revenues between RMB320 million and RMB330 million, reflecting a projected 75.3%-80.8% growth.
So-Young International Inc. (NASDAQ: SY) will report its financial results for Q4 and the full year ended December 31, 2020, on March 22, 2021, before U.S. markets open. The earnings conference call is scheduled for the same day at 7:30 AM ET. Due to COVID-19, participants must preregister online to receive dial-in details. So-Young is recognized as the leading social community for the medical aesthetics industry in China, providing reliable information and connecting consumers with vetted service providers.
So-Young International Inc. (SY) reported Q3 2020 revenues of RMB359.6 million (US$53.0 million), up 18.9% year-over-year. Net income dropped to RMB0.9 million (US$0.1 million) from RMB31.6 million in Q3 2019. Non-GAAP net income was RMB26.4 million (US$3.9 million), down from RMB40.5 million in the previous year. Active mobile users reached 8.7 million, growing 153.7%. The company forecasts Q4 revenues between RMB420 million and RMB450 million, reflecting a year-over-year increase of 17.3% to 25.6%, amid ongoing COVID-19 impacts.
So-Young International Inc. (NASDAQ: SY) will report its Q3 financial results on November 25, 2020, before U.S. markets open. The earnings conference call is set for the same day at 7:00 AM ET. Due to COVID-19, preregistration is required for participants, who can register online to receive dial-in details. The call will also be available for replay until December 3, 2020. So-Young is the largest social community in China for the medical aesthetics industry, focusing on providing reliable information, high-quality content, and curated service providers.
So-Young International Inc. (Nasdaq: SY) reported its unaudited financial results for Q2 2020, showing total revenues of RMB328.2 million (US$46.5 million), a 15.2% year-over-year increase. However, net income dropped significantly to RMB2.1 million (US$0.3 million) from RMB29.3 million in Q2 2019. Non-GAAP net income also fell to RMB30.1 million (US$4.3 million) from RMB102.2 million. The company saw a 173.7% surge in average mobile monthly active users to 6.8 million. Looking ahead, So-Young expects revenues between RMB340 million and RMB370 million for Q3 2020.